Evidence map›Paper›PMID 30462185›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

The Relative Impact of Community and Hospital Antibiotic Use on the Selection of Extended-spectrum Beta-lactamase-producing Escherichia coli.

Derek R MacFadden, David N Fisman, William P Hanage, Marc Lipsitch

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Antimicrobial resistance in commensalJAC-antimicrobial resistance · 2022
    Article
  8. Article
  9. Ethics and antibiotic resistance.British medical bulletin · 2022
    Article
  10. Article
  11. The impact of COVID-19 on community antibiotic use in Canada: an ecological study.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Article
  12. Antimicrobial-ResistantFrontiers in microbiology · 2022
    Article
  13. Review
  14. Article
  15. The role of "spillover" in antibiotic resistance.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. Rates of increase of antibiotic resistance and ambient temperature in Europe: a cross-national analysis of 28 countries between 2000 and 2016.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Derek R MacFaddenHarvard TH Chan School of Public Health, Boston, Massachusetts.
David N FismanDivision of Infectious Diseases, Department of Medicine, University of Toronto, Ontario, Canada.
William P HanageHarvard TH Chan School of Public Health, Boston, Massachusetts.
Marc LipsitchHarvard TH Chan School of Public Health, Boston, Massachusetts.

Funding

Understanding and controlling antibiotic resistanceU54GM088558 · NIGMS · HARVARD SCHOOL OF PUBLIC HEALTH · PI LIPSITCH, MARC · 2009 to 2018
$26.4M
Epidemiology of Infectious Diseases and BiodefenseT32AI007535 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GRAD, YONATAN H, MURRAY, MEGAN B · 1998 to 2025
$4.8M
Ecological and genetic contributions to the spread of resistance in pneumococcusR01AI106786 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI HANAGE, WILLIAM · 2013 to 2017
$3.1M
NCEZID CDC HHS U01 CK000538NIAID NIH HHS R01 AI106786NIAID NIH HHS T32 AI007535NIGMS NIH HHS U54 GM088558
6 · The paper itself

Abstract

Antibiotic stewardship programs have traditionally focused on reducing hospital antibiotic use. However, reducing community antibiotic prescribing could have substantial impacts in both hospital and community settings. We developed a deterministic model of transmission of extended-spectrum beta-lactamase-producing Escherichia coli in both the community and hospitals. We fit the model to existing, national-level antibiotic use and resistance prevalence data from Sweden. Across a range of conditions, a given relative change in antibiotic use in the community had a greater impact on resistance prevalence in both the community and hospitals than an equivalent relative change in hospital use. However, on a per prescription basis, changes in antibiotic use in hospitals had the greatest impact. The magnitude of changes in prevalence were modest, even with large changes in antimicrobial use. These data support the expansion of stewardship programs/interventions beyond the walls of hospitals, but also suggest that such efforts would benefit hospitals themselves.

Indexed as

Antimicrobial StewardshipAnti-Bacterial Agentsbeta-LactamasesCross InfectionEscherichia coliEscherichia coli InfectionsHumansModels, TheoreticalSwedenAnti-Bacterial Agentsbeta-Lactamasesantibiotic resistanceantibiotic stewardshipdynamic modelingtransmission

Identifiers

PMID30462185
PMCPMC6771767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.